Dr. Freeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Deaconess Rd
Beth Israel Deaconess Med Ctr Palmer 111
Boston, MA 02215Phone+1 617-632-8454
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1979 - 1982
Brigham and Women's HospitalInternship, Internal Medicine, 1978 - 1979
University of Cape Town Faculty of MedicineClass of 1974
Certifications & Licensure
MA State Medical License 1980 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension Start of enrollment: 2011 Mar 01
- Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy Start of enrollment: 2012 Feb 01
- Hypoglycemia and Autonomic Nervous System Function Start of enrollment: 2004 Jun 08
- Join now to see all
Publications & Presentations
PubMed
- Effect of Hypoglycemia on QT Interval in Individuals with and without Type 2 Diabetes: A Randomized Crossover Trial.Andrea V Haas, Andrew W Koefoed, Johanna Celli, Istvan Bonyhay, Jeffrey White
The Journal of Clinical Endocrinology and Metabolism. 2025-01-09 - Cerebral Blood Flow Dynamics in Neurogenic Orthostatic Hypotension: A Systematic Review and Meta-Analysis.Jacquie R Baker, Paul A Beach, Shaun I Ranada, Aishani Patel, Jennifer Gewandter
Hypertension. 2025-01-01 - Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trial.Karim Saab, Umang Gada, Eva Culakova, Brian Burnette, Carla Jorgensen
Pain Medicine. 2025-01-01
Journal Articles
- State-of-the-Art ReviewRoy Freeman, Mitchell G Miglis, Christopher Gibbons, Pearl Jones, ScienceDirect
Press Mentions
CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024- CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024
- CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative DiseasesMarch 22nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
